PL1982178T3 - Sposoby leczenia zaburzeń afektywnych - Google Patents
Sposoby leczenia zaburzeń afektywnychInfo
- Publication number
- PL1982178T3 PL1982178T3 PL07703327T PL07703327T PL1982178T3 PL 1982178 T3 PL1982178 T3 PL 1982178T3 PL 07703327 T PL07703327 T PL 07703327T PL 07703327 T PL07703327 T PL 07703327T PL 1982178 T3 PL1982178 T3 PL 1982178T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- methods
- affective disorders
- affective
- disorders
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/301—Anxiety or phobic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/302—Schizophrenia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/304—Mood disorders, e.g. bipolar, depression
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06002474 | 2006-02-07 | ||
PCT/EP2007/001044 WO2007090631A1 (en) | 2006-02-07 | 2007-02-07 | Methods for the diagnosis and treatment of affective disorders and cushing's syndromes |
EP07703327.2A EP1982178B1 (en) | 2006-02-07 | 2007-02-07 | Methods for the treatment of affective disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1982178T3 true PL1982178T3 (pl) | 2014-02-28 |
Family
ID=38066498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07703327T PL1982178T3 (pl) | 2006-02-07 | 2007-02-07 | Sposoby leczenia zaburzeń afektywnych |
Country Status (8)
Country | Link |
---|---|
US (1) | US8153127B2 (pl) |
EP (1) | EP1982178B1 (pl) |
CY (1) | CY1114523T1 (pl) |
DK (1) | DK1982178T3 (pl) |
ES (1) | ES2435793T3 (pl) |
PL (1) | PL1982178T3 (pl) |
PT (1) | PT1982178E (pl) |
WO (1) | WO2007090631A1 (pl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2450755T3 (es) * | 2007-10-19 | 2014-03-25 | Genentech, Inc. | Anticuerpos anti-TENB2 modificados por ingeniería genética con cisteína, y conjugados de anticuerpo y fármaco |
US20150030602A1 (en) | 2011-12-23 | 2015-01-29 | Phenoquest Ag | Antibodies for the treatment and diagnosis of affective and anxiety disorders |
CA2936974A1 (en) | 2014-01-21 | 2015-07-30 | Neurocrine Biosciences, Inc. | Crf1 receptor antagonists for the treatment of congenital adrenal hyperplasia |
CN114711192B (zh) * | 2022-04-13 | 2022-11-29 | 中国科学院西北高原生物研究所 | 一种长效抑郁症动物模型的构建试剂盒及构建方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050209181A1 (en) * | 2003-11-05 | 2005-09-22 | Huda Akil | Compositions and methods for diagnosing and treating mental disorders |
NZ579482A (en) | 2004-06-01 | 2011-02-25 | Genentech Inc | Antibody drug conjugates and methods |
-
2007
- 2007-02-07 WO PCT/EP2007/001044 patent/WO2007090631A1/en active Application Filing
- 2007-02-07 PT PT77033272T patent/PT1982178E/pt unknown
- 2007-02-07 ES ES07703327T patent/ES2435793T3/es active Active
- 2007-02-07 EP EP07703327.2A patent/EP1982178B1/en not_active Not-in-force
- 2007-02-07 PL PL07703327T patent/PL1982178T3/pl unknown
- 2007-02-07 US US12/278,023 patent/US8153127B2/en not_active Expired - Fee Related
- 2007-02-07 DK DK07703327.2T patent/DK1982178T3/da active
-
2013
- 2013-10-21 CY CY20131100922T patent/CY1114523T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT1982178E (pt) | 2013-10-24 |
US8153127B2 (en) | 2012-04-10 |
ES2435793T3 (es) | 2013-12-23 |
US20100069463A1 (en) | 2010-03-18 |
EP1982178A1 (en) | 2008-10-22 |
CY1114523T1 (el) | 2016-10-05 |
DK1982178T3 (da) | 2013-09-08 |
WO2007090631A1 (en) | 2007-08-16 |
EP1982178B1 (en) | 2013-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201001047D0 (en) | Methods and compositions for the treatment of neurological disorders | |
EP1981526A4 (en) | ADIPONECTIN FOR THE TREATMENT OF VARIOUS DISORDERS | |
IL208607A0 (en) | Improved nanobodiestm for the treatment of aggregation-mediated disorders | |
EP1976377A4 (en) | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | |
EP1983972A4 (en) | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | |
IL195203A0 (en) | Compounds for the treatment of metabolic disorders | |
ZA200900734B (en) | Combination treatment for metabolic disorders | |
HK1152939A1 (en) | Carboxamide compounds for the treatment of metabolic disorders | |
IL192692A0 (en) | Compounds for the treatment of inflammatory disorders | |
IL194189A0 (en) | Combination treatment of metabolic disorders | |
ZA201001262B (en) | Interval therapy for the treatment of tinnitus | |
IL192852A0 (en) | Compounds for the treatment of metabolic disorders | |
ZA200806455B (en) | Use of 2-imidazoles for the treatment of CNS disorders | |
IL193799A0 (en) | New therapeutic combinations for the treatment or prevention of psycotic disorders | |
IL192877A0 (en) | Use of 2-imidazoles for the treatment of cns disorders | |
IL192851A0 (en) | Compounds for the treatment of metabolic disorders | |
PL1982178T3 (pl) | Sposoby leczenia zaburzeń afektywnych | |
IL195392A0 (en) | Compounds for the treatment of metabolic disorders | |
EP2328584A4 (en) | TREATMENT OF NEUROLOGICAL DISORDERS USING HUPERZINE | |
SI2278962T1 (sl) | Postopki za zdravljenje dermatoloških motenj | |
GB0604782D0 (en) | Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders | |
HK1129112A1 (en) | 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders | |
EP2240024A4 (en) | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | |
IL192982A0 (en) | Compounds for the treatment of metabolic disorders | |
HK1145282A1 (en) | Treatment of sleep disorders |